Zofran MDL Judge Denies Dismissal For Lack Of ‘Clear Evidence’ Of FDA Action

(January 25, 2016, 1:45 PM EST) -- BOSTON — GlaxoSmithKline LLC’s attempt to dismiss the Zofran multidistrict litigation before discovery began is premature, a Massachusetts federal judge ruled Jan. 22 (In Re: Zofran [Ondansetron] Products Liability Litigation, MDL...
To view the full article, register now.